HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECHA Targets Cosmetic Preservatives For Review With Draft CoRAP Update

This article was originally published in The Rose Sheet

Executive Summary

German and Italian authorities will evaluate the endocrine-disrupting potential of preservatives ethylparaben and benzoic acid, respectively, under the draft Community Rolling Action Plan released by the European Chemicals Agency at the end of October. The annually updated list includes 22 newly added substances overall.

You may also be interested in...



ECHA To Ramp Up REACH Compliance Checks, Targeting 30% Of All Registered Substances By 2027

Noncompliance with REACH information requirements remains an issue of concern for European authorities. ECHA aims to attack the problem by increasing the amount of compliance checks it performs while working with industry to drive improvements and national authorities to strengthen enforcement.

REACH Registrants Should Bone Up On Alternative Test Requirements – ECHA

The European Chemicals Agency examined 164 animal testing proposals last year under the EU’s REACH regulation, resulting in 133 draft decisions seeking additional information, according to its 2016 Progress Report, which includes recommendations for existing and prospective registrants. The agency has implemented a tightened approach to ensure that animal testing is undertaken only as a “last resort.”

EC Releases Endocrine-Disruptor Criteria, Drawing Heavily On WHO Definitions

The European Commission’s newly released criteria for identifying endocrine disruptors in the plant-protection and biocidal product sectors have no direct regulatory impact on cosmetics, but could signal the approach the EC will take in other areas as it works to manage endocrine-disruptor risks. A review of the Cosmetics Regulation’s applicability to endocrine disruptors is nearing completion, the EC says.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108674

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel